OliX Non-Registered Director Exercises Stock Purchase Rights, Slightly Increases Stake
Kim Kelly Kyung Mi, a non-registered director of OliX Pharmaceuticals, exercised stock purchase rights on May 26, 2026, acquiring 3,000 common shares at 22,300 KRW per share.
This increased her holdings from 3,000 shares (0.01%) to 6,000 shares (0.03%) of total outstanding 22,301,830 shares, a negligible change.
[AI Summary]The minor insider stake change has no direct impact on shareholder value, but insider buying may be interpreted as a positive signal of management confidence.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders